Related Experiment Videos
Pneumococcal vaccination of elderly individuals
M Fattal-German1, J Taillandier, D Mathieu
1Department of Molecular Toxinology, Institut Pasteur, Paris, France.
Vaccine
|August 1, 1991
Summary
Pneumococcal infections pose significant risks to older adults. Pneumococcal vaccination is recommended, and this study shows it effectively increases protective antibodies in most elderly individuals, especially when combined with immune support.
Area of Science:
- Immunology
- Gerontology
- Infectious Diseases
Background:
- Pneumococcal infections contribute significantly to morbidity and mortality in elderly populations.
- Antibiotic treatments for pneumococcal infections have limitations, highlighting the need for preventative strategies.
- Vaccination is a key strategy for preventing pneumococcal disease in older adults.
Purpose of the Study:
- To evaluate the immune response to pneumococcal vaccination in elderly individuals aged 60-90 years.
- To assess the protective antibody levels post-vaccination.
- To investigate the effect of combining pneumococcal vaccination with non-specific immunostimulation.
Main Methods:
- Sera from elderly participants (aged 60-90) were analyzed for antipneumococcal antibody levels before and after vaccination.
- Antibody levels were measured to determine protection.
- A subset of participants received vaccination combined with non-specific immunostimulation.
Main Results:
- Most participants had pre-existing antipneumococcal antibodies.
- Vaccination led to increased antibody levels in all but two subjects.
- Nineteen out of twenty vaccinees achieved protective antibody levels post-vaccination.
- Combined vaccination and immunostimulation enhanced the antibody response.
Conclusions:
- Pneumococcal vaccination is effective in inducing protective antibody levels in the majority of elderly individuals.
- The combination of pneumococcal vaccination with non-specific immunostimulation can further enhance the immune response.
- Vaccination remains a critical intervention for reducing the burden of pneumococcal infections in the elderly.